Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 4, 2003, Pages 645-650

  Gustafsson, Ingegerd ^a   Sjölund, Maria ^a   Torell, Erik ^a   Johannesson, Marie ^a   Engstrand, Lars ^a,b   Cars, Otto ^a,b   Andersson, Dan I ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Antibiotic treatment; Human microflora; Mutators; Selection

Indexed keywords

AGAR; AMINOGLYCOSIDE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; MACROLIDE; PENICILLIN G; QUINOLONE DERIVATIVE; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMMENSALISM; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EXPOSURE; ENTEROCOCCUS; ESCHERICHIA COLI; GEOMETRY; HUMAN; INTESTINE FLORA; MICROFLORA; MUTATION RATE; NONHUMAN; NOSE MUCOSA; NUCLEOTIDE SEQUENCE; PHARYNX; PRIMARY HEALTH CARE; STAPHYLOCOCCUS; STRAIN DIFFERENCE; STREPTOCOCCUS; SWEDEN;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; HUMANS; MIDDLE AGED; MUTATION; STAPHYLOCOCCUS;

EID: 0141963052     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg427     Document Type: Article

References (27)

1. Sullivan, A., Edlund, C. & Nord, C. E. (2001). Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infectious Diseases 1, 101-14.
2. Sjölund, M., Wreiber, K., Andersson, D. I. et al. (2003). Long-term persistence of resistant Enterococcus species after antibiotic treatment to eliminate Helicobacter pylori. Annals of Internal Medicine, in press.
3. Matic, I., Radman, M., Taddei, F. et al. (1997). Highly variable mutation rates in commensal and pathogenic Escherichia coli. Science 277, 1833-4.
4. Giraud, A., Radman, M., Matic, I. et al. (2001). The rise and fall of mutator bacteria. Current Opinion in Microbiology 4, 582-5.
5. LeClerc, J. E., Li, B., Payne, W. L. et al. (1996). High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274, 1208-11.
6. Oliver, A., Canton, R., Campo, P. et al. (2000). High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251-4.
7. Denamur, E., Bonacorsi, S., Giraud, A. et al. (2002). High frequency of mutator strains among human uropathogenic Escherichia coli isolates. Journal of Bacteriology 184, 605-9.
8. Björkholm, B., Sjölund, M., Falk, P. G. et al. (2001). Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proceedings of the National Academy of Sciences, USA 98, 14607-12.
9. Miller, J. H. (1998). Mutators in Escherichia coli. Mutation Research 409, 99-106.
10. Oliver, A., Baquero, F. & Blazquez, J. (2002). The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Molecular Microbiology 43, 1641-50.
11. Taddei, F., Radman, M., Maynard-Smith, J. et al. (1997). Role of mutator alleles in adaptive evolution. Nature 387, 700-2.
12. Giraud, A., Matic, I., Tenaillon, O. et al. (2001). Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science 291, 2606-8.
13. Tanabe, K., Kondo, T., Onodera, Y. et al. (1999). A conspicuous adaptability to antibiotics in the Escherichia coli mutator strain, dnaQ49. FEMS Microbiology Letters 176, 191-6.
14. Mao, E. F., Lane, L., Lee, J. et al. (1997). Proliferation of mutators in a cell population. Journal of Bacteriology 179, 417-22.
15. World Health Organization. (2001). WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDD. WHO, Oslo, Norway.
16. Jin, D. J. & Gross, C. A. (1988). Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. Journal of Molecular Biology 202, 45-58.
17. Timms, A. R., Steingrimsdottir, H., Lehmann, A. R. et al. (1992). Mutant sequences in the rpsL gene of Escherichia coli B/r: mechanistic implications for spontaneous and ultraviolet light mutagenesis. Molecular and General Genetics 232, 89-96.
18. Giraud, A., Matic, I., Radman, M. et al. (2002). Mutator bacteria as a risk factor in treatment of infectious diseases. Antimicrobial Agents and Chemotherapy 46, 863-5.
19. Negri, M. C., Lipsitch, M., Blazquez, J. et al. (2000). Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance. Antimicrobial Agents and Chemotherapy 44, 2485-91.
20. Edlund, C., Lindqvist, L. & Nord, C. E. (1988). Norfloxacin binds to human fecal material. Antimicrobial Agents and Chemotherapy 32, 1869-74.
21. Hoiby, N., Jarlov, J. O., Kemp, M. et al. (1997). Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet 349, 167-9.
22. Zhao, X. & Drlica, K. (2001). Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clinical Infectious Diseases 33, Suppl. 3, S147-56.
23. Martinez, J. L. & Baquero, F. (2000). Mutation frequencies and antibiotic resistance. Antimicrobial Agents and Chemotherapy 44, 1771-7.
24. Denamur, E., Lecointre, G., Darlu, P. et al. (2000). Evolutionary implications of the frequent horizontal transfer of mismatch repair genes. Cell 103, 711-21.
25. Drlica, K. & Zhao, X. (1997). DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiology and Molecular Biology Reviews 61, 377-92.
26. Levy, S. B., Marshall, B., Schluederberg, S. et al. (11988). High frequency of antimicrobial resistance in human fecal flora. Antimicrobial Agents and Chemotherapy 32, 1801-6.
27. Lang, A., De Fina, G., Meyer, R. et al. (2001). Comparison of antimicrobial use and resistance of bacterial isolates in a haematology ward and an intensive care unit. European Journal of Clinical Microbiology and Infectious Diseases 20, 657-60.